Internal Medicine, Hematology & Oncology · Flushing, NY
NPI
1578882858
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
5645 Main St
Flushing, NY, 11355
Phone (718) 670-1180
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
825 services
Medicare patients, 2024
176
Average age 77
Drug cost, 2024
$6.0M
1,053 prescriptions
Company payments, 2025
$22K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashish Saxena was code 99214 (office e&m - established), 629 times for 112 patients. In total Ashish Saxena billed 825 services in 11 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 629 | 112 | $86.63 | $54K |
| 99213 Office E&M - Established | Facility | 62 | 39 | $57.21 | $3,547 |
| 99205 Office E&M - New | Facility | 47 | 47 | $168.18 | $7,905 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 17 | $111.22 | $3,670 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $155.99 | $2,340 |
| 99215 Office E&M - Established | Facility | 13 | 12 | $135.74 | $1,765 |
By year: 2022 $74K for 765 services; 2023 $75K for 843 services; 2024 $76K for 825 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashish Saxena prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 236 prescriptions and refills. In total Ashish Saxena wrote 1,053 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 236 | 238 | 43 | $3.9M |
| Ondansetron Odt Ondansetron | 85 | 93 | 43 | $2,138 |
| Eliquis Apixaban | 42 | 42 | 11 | $24K |
| Entecavir Generic | 38 | 49 | 13 | $11K |
| Dexamethasone Generic | 35 | 35 | 12 | $238 |
| Prednisone Generic | 34 | 38 | 14 | $128 |
| Alecensa Alectinib Hcl | 29 | 29 | Under 11 | $497K |
| Oxycodone Hcl Generic | 26 | 26 | Under 11 | $407 |
| Folic Acid Generic | 26 | 54 | 12 | $220 |
| Alprazolam Generic | 26 | 26 | Under 11 | $121 |
| Gavreto Pralsetinib | 21 | 21 | Under 11 | $371K |
| Levothyroxine Sodium Generic | 20 | 44 | Under 11 | $227 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 19 | 19 | Under 11 | $197 |
| Olanzapine Generic | 19 | 19 | Under 11 | $45.5 |
| Triamcinolone Acetonide Generic | 19 | 19 | 12 | $170 |
Brand drugs: - claims; generic drugs: 624 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashish Saxena $22K ($22K in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 10 | $17K |
| Galvanize Therapeutics, Inc | 3 | $2,011 |
| Genentech USA, Inc. ROG.SW | 2 | $1,783 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $187 |
| AstraZeneca UK Limited AZN | 1 | $135 |
| Stemline Therapeutics Inc. | 2 | $49.75 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $31.32 |
| Merck Sharp & Dohme LLC MRK | 1 | $22.27 |
| Array Biopharma Inc PFE | 1 | $20.96 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $19.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.